Clinical Trial Update: Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of the G17DT immunogen in gastric and gastroesophageal cancers has completed. The document summarizes the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• G17DT immunogen

Snippet

Sponsor: Cancer Advances Inc. | Conditions: Stomach Neoplasms, Esophageal Neoplasms | Phase 2 | Status: COMPLETED